Table 3: Distribution of Mn-SOD (Ala16Val) polymorphism in patients with RCC and controls.

Mn-SODPatients
Control
OR (95% CI)

Mn-SOD0.05
ALA16VAL
 Ala/Ala14 [34%]8 [16%]
 Ala/Val17 [42%]19 [38%]
 Val/Val10 [24%]23 [46%]
(Ala/Ala + Ala/val)31 [76%]27 [54%] 2.64 (1.06–6.69)
Val/Val10 [24%]23 [46%]
Allele frequency 2.26 (1.24–4.12)
  Ala45 [55%]35 [35%]
  Val37 [45%]65 [65%]

There was statistically significant difference between groups.